ADJUVANT CHEMOTHERAPY OF BREAST CANCER: REALITY, HOPE, HAZARD?
- 26 December 1981
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 318 (8260) , 1413-1414
- https://doi.org/10.1016/s0140-6736(81)92820-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Treatment of Primary Breast Cancer with Chemotherapy and TamoxifenNew England Journal of Medicine, 1981
- Dose-Response Effect of Adjuvant Chemotherapy in Breast CancerNew England Journal of Medicine, 1981
- Adjuvant chemotherapy for breast cancer: side effects and quality of life.BMJ, 1980
- NIH Consensus-Development StatementNew England Journal of Medicine, 1980
- CANCER CHEMOTHERAPY—WHAT HAVE WE ACHIEVED?The Lancet, 1980
- 1-Phenylalanine mustard (L-PAM) in the management of premenopausal patients with primary breast cancer.Lack of association of disease-free survival with depression of ovarian functionCancer, 1979
- Prevalence of mitral valve prolapse in presumably healthy young men.Circulation, 1979
- Mitral valve prolapse in one hundred presumably healthy young females.Circulation, 1976
- Late systolic murmurs and non-ejection ("mid-late") systolic clicks. An analysis of 90 patients.Heart, 1968
- Symptomatic Valvular Myxomatous Transformation (The Floppy Valve Syndrome)Circulation, 1965